100% SVR4 with ABT-493 and ABT-530 with or without ribavirin in treatment-naive HCV genotype 3-infected patients with cirrhosis
Publication Type:
Journal Article
Authors:
Kwo, P.Y.;
Wyles, D.L.;
Wang, S.;
Poordad, F.;
Gane, E.;
Maliakkal, B.;
Shiffman, M.L.;
Ng, T.I.;
Lin, C.-W.;
Liu, R.;
Kort, J.;
Mensa, F.J.Source:
J Hepatol, Volume 64, Issue 2, p.S208 (2016)
